Ovarian Cancer: Low Dose Naltrexone as a Possible Treatment

The following research article on PubMed concluded Low Dose Natrexone (LDN) to be a beneficial treatment option for ovarian cancer.  The following results were stated:

“These preclinical data may offer a non-toxic and efficacious pathway-related treatment that can benefit patients with ovarian cancer.”

CLICK HERE to read more